(Taken from ParaTech website)
The PROCTO trial is a double-blind randomized, placebo-controlled, 24-week, comparative, exploratory phase II proof of concept trial. The trial will be conducted with 2 treatment groups as a parallel group comparison and will serve to compare a 7500 Trichuris suis ova regimen vs. placebo for achieving clinically meaningful responses in ulcerative colitis (UC). The study is conducted in collaboration between 3 Danish hospitals: Hvidovre Hospital, Herlev Hospital and Bispebjerg Hospital.
For more information